These findings demonstrate that NRF2 deletion in KRASG12D-mutant pancreatic epithelium not only suppresses PanIN formation, as seen in full-body knockout models, but also increases the likelihood of developing IPMN-like cystic lesions. The gene discussed is NFE2L2; the disease is pancreatic intraductal papillary-mucinous neoplasm.